<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:department>Oxford Chemistry</gtr:department><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/B6339638-7179-424B-A08E-AF3937B9474E"><gtr:id>B6339638-7179-424B-A08E-AF3937B9474E</gtr:id><gtr:firstName>Christoph</gtr:firstName><gtr:surname>Loenarz</gtr:surname><gtr:orcidId>0000-0002-8843-2531</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/938311FB-2998-4FA4-B30A-447B6572B1C0"><gtr:id>938311FB-2998-4FA4-B30A-447B6572B1C0</gtr:id><gtr:firstName>Christopher Joseph</gtr:firstName><gtr:surname>Schofield</gtr:surname><gtr:orcidId>0000-0002-0290-6565</gtr:orcidId><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/A902DB7E-5D05-49BC-BCD5-901CA428016D"><gtr:id>A902DB7E-5D05-49BC-BCD5-901CA428016D</gtr:id><gtr:firstName>Peter</gtr:firstName><gtr:otherNames>John</gtr:otherNames><gtr:surname>Ratcliffe</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BB%2FL004275%2F1"><gtr:id>9A79E1D9-6CD8-4329-9384-7032D494A158</gtr:id><gtr:title>Analysis and Exploitation of Oxygen-Dependent Modification to Ribosomes</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>BB/L004275/1</gtr:grantReference><gtr:abstractText>Ribosomes are intracellular machines that make proteins, but they also contain proteins. Recent BBSRC funded work led to the discovery that ribosomal proteins undergo a modification, termed hydroxylation, dependent on atmospheric oxygen at sites of importance for protein biosynthesis. One of the largest classes of antibiotics, e.g. erythromycin, targets ribosomes. Point mutations to ribosomes confer resistance to such antibiotics. Hence it should be possible to develop compounds that selectively target unmodified over modified ribosomes. Tumour cells are often hypoxic so should contain ribosomes that are ales hydroxylated than normal cells. We propose to use Follow on Funding to test synthetically modified antibiotics (guided by ribosome structures) to identify compounds that selectively inhibit unmodified over modified (or vice versa) ribosomes. The results will be used to support patent applications and, if appropriate, to form a spin-out company.</gtr:abstractText><gtr:fund><gtr:end>2015-02-28</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2014-03-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>195089</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Informa Life Sciences' Enzymes Event, London</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>E51EDF08-6ACD-4B5C-A267-675CDE9526BB</gtr:id><gtr:impact>Talk at Informa Life Sciences' Enzymes Event, London on &amp;quot;Protein Hydroxylation by Oxygenases&amp;quot;</gtr:impact><gtr:outcomeId>56d71ff300c395.84375261</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Gordon Research Conference, Ventura, California, USA</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>E9F0D052-450A-405F-A762-E31A5F0A5947</gtr:id><gtr:impact>Presentation at Gordon Research Conference, Ventura, California, USA on &amp;quot;Roles of Oxygenases in Hypoxia Sensing&amp;quot;</gtr:impact><gtr:outcomeId>56d720b0e42c11.73799295</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Lilly Conference</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>1F02BB3A-C0C4-4D08-88A0-ACBE94DFDE5E</gtr:id><gtr:impact>Presentation at Lilly's Chemical Biology meets Drug Discover conference on &amp;quot;Chemical Biology of Oxygen Sensing&amp;quot;</gtr:impact><gtr:outcomeId>56d734aa13cc47.33972948</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Oxford Transcription Meeting</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>BC3D3C20-9C16-4623-BFE3-55CFBDCD68F6</gtr:id><gtr:impact>Talk at Oxford Transcription Meeting on &amp;quot;Studies on the regulation of transcription by oxygen&amp;quot;</gtr:impact><gtr:outcomeId>56d71eebf29811.82010205</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>ELRIG Meeting, Telford</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>4723AAF9-7D3F-493B-B364-7ECFBB4905AC</gtr:id><gtr:impact>Talk at The European Laboratory Research &amp;amp; Innovation Group Meeting in Telford on &amp;quot;Targeting Oxygenases for the Regulation of Protein Biosynthesis&amp;quot;</gtr:impact><gtr:outcomeId>56d71db536be11.89418941</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Proteomics Meeting COST, Oxford</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>DAC23726-1D47-40F5-9AC8-80E7F9EB9A1C</gtr:id><gtr:impact>Talk at Proteomics Meeting COST, Oxford on &amp;quot;Proteomics for Functional Assignment of Oxygenases (is Hard Work)&amp;quot;</gtr:impact><gtr:outcomeId>56d71f6ca24652.92117128</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Society of Chemical Industry's London Region Committee, New York University London</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>1573EF35-EDFA-4F26-86C0-C06FD737D5EB</gtr:id><gtr:impact>Talk at Society of Chemical Industry's London Region Committee, New York University London on &amp;quot;The chemistry of oxygen sensing in humans and bacteria (from antibiotics to epigenetics and back again)&amp;quot;</gtr:impact><gtr:outcomeId>56d732a2529135.59151045</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Industry/Business</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Seminar at Plant Sciences</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>F325089F-0D9B-49D7-8C9B-30A3E2094C4F</gtr:id><gtr:impact>Seminar on 'Oxygenases as Hypoxia Sensors in Humans, Plants, and Other Organisms'</gtr:impact><gtr:outcomeId>56d71752758ca9.92047643</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>GRC Enzyme, coenzymes and Metabolic Pathways, Waterville, USA</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>B7014CDB-FCA1-46EA-AF12-F076B804CECB</gtr:id><gtr:impact>Presentation Gordon Research Conference, Waterville, USA on &amp;quot;The Enzymology of Oxygen Sensing in Humans and Other Organisms&amp;quot;</gtr:impact><gtr:outcomeId>56d733be606434.69110196</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>The work has impacted on antimicrobial resistance research (by defining a new type of oxygenase catalysed resistance mechanism). The methods developed will also be useful in research targeting prokaryotic oxygenases (for antibacterial resistance) and human oxygenases for diseases ranging from cancer. Specifically, they enable the quantitative mass spectrometric based analyses of the activities of oxygenases to be measured in a cellular context. The methods are useful both in terms of developing inhibition of oxygenases acting on ribosomes, and of measuring 'off target' inhibition of such oxygenases by inhibitors targeting other oxygenases, e.g. the hypoxia inducible factor prolyl hydroxylases for the treatment of anaemia, or the JmjC histone demethylases for the treatment of cancer.</gtr:description><gtr:id>E0E0A28B-22BE-49E5-AEA6-A96037BCDA03</gtr:id><gtr:impactTypes><gtr:impactType>Societal</gtr:impactType></gtr:impactTypes><gtr:outcomeId>546380cc1c4b39.95732715</gtr:outcomeId><gtr:sector>Chemicals,Healthcare,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>The key technical objectives of the work have all been achieved, i.e. we optimised mass-spectrometric methods for the analysis of ribosomal proteins, developed new methods for the synthesis of modified antibiotics targeting ribosomes (new collaboration with Professor Darren Dixon, Department of Chemistry, Oxford, which has resulted in a publication on synthesis), and carried out cell based studies with a range of antibiotics to test the hypothesis that ribosomal proteins differentially modified by oxygenases would show different sensitivities to antibiotics binding close to the location of the modification (hydroxylation). These results are presently being written up for publication and, maybe, a patent application. Furthermore, the methods that we have developed have proven to be useful in our basic science work on post-translational modifications catalysed by oxygenases.</gtr:description><gtr:exploitationPathways>Most of the work has focused on obtaining reliable data on prokaryotic cells, but we have also initiated work on human cells, the preliminary results of which will form the basis of a future large-scale application in the cancer field.</gtr:exploitationPathways><gtr:id>F234D627-F968-49EC-B651-35DF5F44BEA0</gtr:id><gtr:outcomeId>56def0c08593c0.03460799</gtr:outcomeId><gtr:sectors><gtr:sector>Chemicals,Healthcare,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>EF8B8C77-4726-4E1B-925C-07F201ADBD3F</gtr:id><gtr:title>Targeting Protein-Protein Interactions in the HIF System.</gtr:title><gtr:parentPublicationTitle>ChemMedChem</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e5cc1397c7fb5fb5593e914b680ac490"><gtr:id>e5cc1397c7fb5fb5593e914b680ac490</gtr:id><gtr:otherNames>Wilkins SE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1860-7179</gtr:issn><gtr:outcomeId>577d10f8d37dc0.32813569</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D82F8197-E05E-4B9E-9EDF-824C0439A641</gtr:id><gtr:title>Sudestada1, a Drosophila ribosomal prolyl-hydroxylase required for mRNA translation, cell homeostasis, and organ growth.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/edd8047364797ec869c89f40f46ac93c"><gtr:id>edd8047364797ec869c89f40f46ac93c</gtr:id><gtr:otherNames>Katz MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>54637ba5913131.23191660</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A3A72045-2B34-4084-A753-A524CE018E6A</gtr:id><gtr:title>Pharmacological targeting of the HIF hydroxylases--A new field in medicine development.</gtr:title><gtr:parentPublicationTitle>Molecular aspects of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f0ca40f3ffbff7ce1bc16f3cc322e90d"><gtr:id>f0ca40f3ffbff7ce1bc16f3cc322e90d</gtr:id><gtr:otherNames>Chan MC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0098-2997</gtr:issn><gtr:outcomeId>56d5da00d89ee8.23079221</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DC563890-4E88-4EA7-821F-BD9639B6A869</gtr:id><gtr:title>Betti reaction enables efficient synthesis of 8-hydroxyquinoline inhibitors of 2-oxoglutarate oxygenases.</gtr:title><gtr:parentPublicationTitle>Chemical communications (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/315d6bc98f5461e589680d2b00b9069c"><gtr:id>315d6bc98f5461e589680d2b00b9069c</gtr:id><gtr:otherNames>Thinnes CC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1359-7345</gtr:issn><gtr:outcomeId>56d5da0225df78.44027188</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>42FFF8F8-BF33-40B2-ABF2-B9EC9ED5467A</gtr:id><gtr:title>Ribosomal oxygenases are structurally conserved from prokaryotes to humans.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e6174ca4b9befe9d94477e7180f705a2"><gtr:id>e6174ca4b9befe9d94477e7180f705a2</gtr:id><gtr:otherNames>Chowdhury R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>54637220595c52.34951391</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>88C91CFB-1A54-478D-8372-35875E0DF35E</gtr:id><gtr:title>8-Substituted Pyrido[3,4-d]pyrimidin-4(3H)-one Derivatives As Potent, Cell Permeable, KDM4 (JMJD2) and KDM5 (JARID1) Histone Lysine Demethylase Inhibitors.</gtr:title><gtr:parentPublicationTitle>Journal of medicinal chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6aa68bffb8778b1c3e9721b2f547ae70"><gtr:id>6aa68bffb8778b1c3e9721b2f547ae70</gtr:id><gtr:otherNames>Bavetsias V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-2623</gtr:issn><gtr:outcomeId>56dd7d17d39508.25014822</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8D75ECC2-0191-4D07-9B4D-99B7C03E2DC9</gtr:id><gtr:title>Expanding the yeast protein arginine methylome.</gtr:title><gtr:parentPublicationTitle>Proteomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/830d79129a4f8be5913a3249b231ba6f"><gtr:id>830d79129a4f8be5913a3249b231ba6f</gtr:id><gtr:otherNames>Plank M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1615-9853</gtr:issn><gtr:outcomeId>5697d155d64757.33149672</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DFF9947D-D0AD-4173-A8CB-E8AFCF0EB91C</gtr:id><gtr:title>Structure of the ribosomal oxygenase OGFOD1 provides insights into the regio- and stereoselectivity of prolyl hydroxylases.</gtr:title><gtr:parentPublicationTitle>Structure (London, England : 1993)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/41d18cbb3ac5afaf1eb59f621462162d"><gtr:id>41d18cbb3ac5afaf1eb59f621462162d</gtr:id><gtr:otherNames>Horita S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0969-2126</gtr:issn><gtr:outcomeId>5697cecf690554.19167800</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A41CA88C-AFCD-4D30-A41F-A8229CBD14A0</gtr:id><gtr:title>Hydroxylation of the eukaryotic ribosomal decoding center affects translational accuracy.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0a9ae3828c3a863983fefd000fae9625"><gtr:id>0a9ae3828c3a863983fefd000fae9625</gtr:id><gtr:otherNames>Loenarz C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>54637b47194469.27708454</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5071F9AC-E5FD-485B-8F06-0DE1B18B11CC</gtr:id><gtr:title>Optimal translational termination requires C4 lysyl hydroxylation of eRF1.</gtr:title><gtr:parentPublicationTitle>Molecular cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/10174f7aa32d3018579433819b40df95"><gtr:id>10174f7aa32d3018579433819b40df95</gtr:id><gtr:otherNames>Feng T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1097-2765</gtr:issn><gtr:outcomeId>546379f624d5c2.00507873</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>663907DB-7D6D-40BB-96B8-7FF7CFE2A084</gtr:id><gtr:title>OGFOD1 catalyzes prolyl hydroxylation of RPS23 and is involved in translation control and stress granule formation.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bfe4d5a73e12e8b514864228f44c86fd"><gtr:id>bfe4d5a73e12e8b514864228f44c86fd</gtr:id><gtr:otherNames>Singleton RS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>54637c09e728e9.38651694</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E6856257-4CD5-416D-B176-6112FD78F058</gtr:id><gtr:title>Protein Hydroxylation Catalyzed by 2-Oxoglutarate-dependent Oxygenases.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e5d90e340706ff84958065e3f43f2ff2"><gtr:id>e5d90e340706ff84958065e3f43f2ff2</gtr:id><gtr:otherNames>Markolovic S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>5697d7874b3c71.42735880</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/L004275/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>